<?xml version="1.0" encoding="UTF-8"?>
<p id="Par3">Previous estimates reported that genotype 1 was the most prevalent (46.2%), followed by 3a (30.1%)
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. Genotypes 2, 4, and 6 account for most of the remaining infections with prevalences estimated at 9.1%, 8.3%, and 5.4%, respectively
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. Genotype 5 was estimated at &lt;1%. Genotypes 1 and 3 have been found globally, whereas genotypes 4 and 5 occur mostly in low-income countries
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. Genotype 1 circulates at highest prevalence in the Americas, Central Europe, and a few countries in Asia; genotype 2 in Western Africa; genotype 3 in Central Asia, Latin America, and Eastern Europe; genotype 4 in North Africa, Central Africa, and the Middle East; genotype 5 in Southern Africa; and genotype 6 in Eastern and Southeast Asia
 <sup>
  <xref ref-type="bibr" rid="CR5">5</xref>
 </sup>. However, the origin of HCV and the global patterns of HCV dissemination remain unknown.
</p>
